Skip to main content
. 2021 Jan 26;11(2):161. doi: 10.3390/brainsci11020161

Table 2.

Annual economic burdens of total direct medical cost per patient in PAC and non-PAC cohorts before and after one-year rehabilitation.

Cost Components PAC Cohort (n = 455) # Non-PAC Cohort (n = 455) Differences
(PAC–non-PAC)
Economic Burden *
Mean ± SD Mean ± SD
Diagnosis fee 4139.5 ± 1798.1 1089.0 ± 157.3
Ward fee 2882.2 ± 560.9
Examination fee 1619.0 ± 373.9
Medicine and pharmacy service fee 450.1 ± 25.1
Rehabilitation therapy fee 1103.5 ± 273.6
Other fees 1785.9 ± 430.9
Total direct medical cost during rehabilitation 4139.5 ± 1798.1 8929.8 ± 1827.1 −4790.3 ± 1805.7
Total direct medical cost after discharge 1187.2 ± 1148.6 1246.0 ± 1203.6 −58.8 ± 35.6
Total direct medical cost 5326.7 ± 1933.5 10,175.8 ± 2377.9 −4849.1 ± 2685.7 −354,886,232.6

PAC, post-acute care; SD, standard deviation; ICER, incremental cost-effectiveness ratio. # Mean direct medical cost for the PAC cohort, hospitals will receive a packaged and function-related reimbursement by day, that is, a maximal packaged imbursement of US $117.6 per day for high-intensity rehabilitation or US $79.0 per day for general-intensity rehabilitation covering whole medical expenses for stroke care, managing associated comorbidities and complications, and rehabilitation. * Economic burden during 1 year after rehabilitation is US $4849.1 per patient × 318.2 patients per 100,000 person-year (age-standardized incidence of first-ever stroke) × 23,000,000 persons (Taiwan nationwide population). Therefore, annual per-patient economic burden of total direct medical cost approximately equals to US $354.6 million.